MANN MICHAEL SCOTT (President) purchased 0.0% of their position (4K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $103.20 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 2/8/2019ACC: 0001645627-19-000005
Officer10% Owner· President
Since Jun 2018
+4K
Net shares
Net buyer
$103.20
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$51.60
% of position
0.0%
2/4/2019
26.70M→26.70M
Common Stock
Direct
Shares
+2K
Price / share
$0.03
Trade value
$51.60
% of position
0.0%
2/4/2019
26.70M→26.70M
Total
Net shares
+4K
Net value
$103.20
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2019 | P · Purchase | +2K | $0.03 | $51.60 | 0.0% | 26.70M | 26.70M |
| Common Stock Direct | 2/4/2019 | P · Purchase | +2K | $0.03 | $51.60 | 0.0% | 26.70M | 26.70M |
| Total | +4K | $103.20 | ||||||
Derivative Transactions0
No derivative transactions reported